Shown here
- The prescription drugs page gaps and known product facts.
- Prescription drugs buyer details grouped before the page is written.
- Prescription drugs title, summary, sections, FAQ, specs, and search fields ready for team review.
Loading the current XEVRIN page. It will open automatically.
Product page improvement
A stronger regulated catalog page should keep identity, strength, package, storage, identifiers, and compliance guardrails clear without adding medical advice.

This prescription drugs example shows the starting record, buyer details added, page draft, and checks still needed before live use.
Use these notes to separate the inputs behind LANTUS SoloStar Insulin Glargine Injection from the checks a live merchant page still needs.
The displayed product photo is a locally cached source image for this demonstration. LANTUS SoloStar manufacturer page · LANTUS manufacturer product image. Confirm image rights before production use.
The before view shows the thin product information a shopper would have to decode. The comparison summarizes what changes, and the complete buyer-facing draft follows immediately below.

The weak record names the medication and a strength, but it does not separate the brand, generic name, NDC, package, route, dosage form, storage rules, labeler, or compliance requirements.
| Item | NDC 0088-2219-05 |
|---|---|
| Unit | Carton of 5 prefilled pens |
| Vertical | Prescription drugs |
The full product-page draft shows package and storage clarity without adding treatment or dosing guidance.

LANTUS SoloStar contains insulin glargine injection 100 units/mL (U-100) in single-patient-use 3 mL prefilled pens. This Rx-only carton contains five pens; pen needles are not included.
| Item Number | NDC 0088-2219-05 |
|---|---|
| Unit | Carton of 5 prefilled pens |
This package is LANTUS SoloStar insulin glargine injection U-100 supplied as five 3 mL prefilled pens under package NDC 0088-2219-05. It is a human prescription drug for subcutaneous use.
Store unused pens in a refrigerator at 36°F to 46°F (2°C to 8°C), do not freeze, and protect them from direct heat and light. Refer to the current approved prescribing information and dispensing label for complete instructions.
The carton contains five single-patient-use LANTUS SoloStar 3 mL prefilled pens. Pen needles are not included.
Package NDC 0088-2219-05 identifies the carton of five LANTUS SoloStar prefilled pens.
Keep unused pens refrigerated at 36°F to 46°F (2°C to 8°C). Do not freeze them, and protect them from direct heat and light.
Use the current FDA-approved prescribing information, dispensing label, and guidance from a qualified healthcare professional. This product summary does not replace those materials.
| Brand Display | LANTUS SoloStar |
|---|---|
| Generic Name | insulin glargine |
| Manufacturer/Labeler | sanofi-aventis U.S. LLC |
| Product Type | Human prescription drug |
| Prescription Status | Rx only |
| Dosage Form | Injection, solution |
| Route | Subcutaneous |
| Strength | 100 units/mL (U-100) |
| Package NDC | 0088-2219-05 |
| Package | 5 single-patient-use 3 mL SoloStar prefilled pens per carton |
| Needles | Not included |
| Unused Storage | Refrigerate at 36°F to 46°F (2°C to 8°C); do not freeze |
| Handling | Protect from direct heat and light |
| In-Use Timing | Use within 28 days after initial use |
These prescription-record details keep label-backed facts separate from copy that would require pharmacy, clinical, or regulatory approval.
5 drug identity details help catalog teams verify regulated identity, package, storage, and blocked-claim boundaries.
5 strength and package details help catalog teams verify regulated identity, package, storage, and blocked-claim boundaries.
4 storage and handling details help catalog teams verify regulated identity, package, storage, and blocked-claim boundaries.
4 compliance guardrails details help catalog teams verify regulated identity, package, storage, and blocked-claim boundaries.
The after record shows how XEVRIN can make regulated product fields clearer without creating medical advice or unsupported compliance claims.
| Field group | Current gap | Buyer detail added | Why it matters |
|---|---|---|---|
| Drug identity | LANTUS PEN | Brand, generic name, dosage form, route, prescription status, and labeler separated | A regulated product record that is easier for pharmacy buyers and catalog teams to understand |
| Package and identifiers | 3 mL pen | NDC 0088-2219-05, five 3 mL SoloStar prefilled pens per carton, needles not included | Cleaner product file and catalog fields for the exact sellable package |
| Strength | 100 units/mL | Strength normalized as insulin glargine 100 units/mL (U-100) | Less ambiguity between brand, generic name, concentration, dosage form, and package |
| Storage and handling | Keep cold | Unused refrigeration range, do-not-freeze handling, heat/light protection, and in-use timing | Important handling details are separated instead of buried in a short note |
Your store page stays buyer-facing. Marketplace outputs are separate field packages for Amazon and Walmart, prepared for destination rules, validation checks, and merchant-controlled values.
Keep NDC, package, storage, Rx status, and compliance gates separate before any marketplace decision.
Prepare regulated product fields only after pharmacy, legal, and seller-program requirements are confirmed.